柱切换-高效液相色谱法测定抗病毒口服液中非法添加利巴韦林

提出了由双泵单阀的驱动系统和双柱(预处理柱和分析柱)切换的分析系统所组成的色谱分析流程并应用于测定抗病毒口服液中非法添加物利巴韦林.样品离心后取上清液直接进样于C18预处理柱,水作为预处理流动相;用0.3 g·L-1磷酸二氢钠溶液(分析流动相)将保留在预处理柱上的药物冲入Kromasil C18分析柱(250 mm×4.6 mm,5μm)进行测定.方法集样品净化和色谱分析一次连续进行,测定条件下无干扰.检测波长205.6 am,药物的质量浓度在0.4～40.0 mg·L-1范围内呈线性(r=0.999 2),检出限(S/N=3)为0.08 mg·L-1,加标回收率分别为98.32%,98.45%,99.45%.     

弱阳离子交换整体柱的制备及其对人血浆中硝苯地平的在线分析

以甲基丙烯酸(MAA)为功能单体,乙二醇二甲基丙烯酸酯(EDMA)为交联剂,以色谱柱管为模具,通过原位聚合法制备了弱阳离子交换整体柱。该柱能去除血浆中的内源性物质,对生物样品中的药物有富集作用。将其作为固相萃取柱与C18色谱柱联用,在线分析了人血浆中的硝苯地平。流动相为甲醇-水(体积比为70∶30),流速1.0 mL/min,检测波长235 nm。结果表明,硝苯地平在5.0～75.0 μg/L范围内线性关系良好(r=0.9993),方法的回收率为90.0%～99.0%,日内、日间相对标准偏差均小于5.0%。该方法精密度高,重现性良好,避免了繁琐的样品预处理过程,且弱离子整体柱可多次重复使用,为检测血浆中的痕量药物提供了一种快速、经济、有效的新方法。     

基于微流控芯片的固相萃取技术的研究进展

作为近年来最前沿的分析技术之一,微流控芯片技术具有高通量、微型化、多功能和集成化等独特优势,目前,该技术主要以生命科学体系为研究对象。但由于生化样品存在基质效应与干扰组分,使得样品分析备受干扰。因此发展微流控芯片中的样品前处理技术,对于样品尤其是复杂的生物样品的纯化和富集极其重要,同时这也是微流控芯片系统走向集成化和微型化必须突破的瓶颈之一。本文针对应用广泛的固相萃取技术,重点综述了微流控芯片上固相萃取技术的几种不同模式即开管柱、填充柱以及整体柱的特点及优缺点,并对微流控芯片系统的发展做出了展望。     

微流控芯片分析系统中硅胶整体柱和膜滤复合预处理单元的构建

以改性C18反相硅胶整体柱为微流控芯片分析系统中固相萃取介质材料, 构建不同功能单元的样品预处理微分析系统, 实现了血清样品中痕量盐酸多巴酚丁胺的富集. 初步构建了单一改性硅胶微柱固相萃取预处理单元, 测试得到了改性硅胶整体柱对血清中痕量盐酸多巴酚丁胺的平均富集倍数为77.2, RSD为12.35％. 为了提高测试的精密度, 进而设计含膜复合式预处理芯片, 探讨了不同预处理单元对血清样品中痕量盐酸多巴酚丁胺富集效率的影响, 优化设计了外接式硅胶整体柱-亲和膜微芯片固相萃取预处理单元, 复合式的反相硅胶整体柱对血清中微量盐酸多巴酚丁胺的平均富集倍数提高到89.4, RSD为4.37％. 结果显示了该预处理单元在血清中痕量药物富集的可行性和有效性.     

液相色谱-串联质谱法测定人血浆中的维拉帕米

维拉帕米（Verapamil,Ver）是第一代钙离子拮抗剂,临床上主要用于心律失常、心绞痛和高血压的治疗。有关生物样品中Ver的分析方法报道较多,主要有高效液相色谱（HPLC）-紫外检测法、HPLC-荧光检测法和高效毛细管电泳法,但色谱分析时间均大于8min。最近有文献报道采用液相色谱-串联质谱法（LC—MS／MS）测定人血浆中Ver及其活性代谢物去甲维拉帕米的对映异构体。本文旨在建立一种专属、快速、灵敏的LC—MS／MS用于测定人血浆中的Ver,以研究该药在体内的药代动力学特点。     

高效液相色谱法直接测定血浆中的丝裂霉素C

本实验采用两根反相柱串联而形成的高效液相色谱柱切换装置，直接进样测定血浆中抗癌药物丝裂霉素Ｃ。第一根柱利用胶束流动相进行样品的纯化和富集，第二根柱对药物进行分析。紫外检测波长为３６５ｎｍ。药物的回收率在９５．９％～１００．３％之间，相对标准偏差为２．７６％。用该法对人和狗的局部和全身注射药物的血浆样品进行了测定。     

沃特世公司成功举办生物样品分析研讨会

2012年1月11日,由沃特世(Waters)公司发起的"沃特世生物样品分析研讨会"在上海成功举办,来自上海地区生物分析领域的专家出席了此次会议。当前,在分析血浆、尿液、这些复杂基质的生物样品时,面临的最大挑战就是基质效应,因此在进行LC/MS分析前如何选择最合适的前处理方法来消除"离子抑制或离子增强"作用成为科学家们最关心的问     

液相色谱-串联质谱法同时测定血浆中白藜芦醇苷及其代谢产物

建立同时测定大鼠血浆中白藜芦醇苷及其代谢产物白藜芦醇的液相色谱-串联质谱方法。以Lichro-spher C18色谱柱为分析柱,乙腈-水为流动相,采用电喷雾离子源(ESI),以多反应监测(MRM)模式检测,内标法定量,用于定量分析的离子反应分别为m/z389/227(白藜芦醇苷)和m/z227/143(白藜芦醇)。血浆中的白藜芦醇苷及白藜芦醇用乙酸乙酯提取,N2吹干乙酸乙酯,残留物用甲醇溶解,注入LC/MS/MS系统进行检测。在选定的样品预处理、色谱及质谱条件下,白藜芦醇苷、白藜芦醇及内标物能够达到基线分离而且离子化效果好。用LC/MS/MS法检测大鼠血浆中的白藜芦醇苷及其代谢产物白藜芦醇,线性范围0.4~200μg/L,日内、日间精密度(RSD)均小于15%;检测血浆低、中、高3个浓度(1、20、100μg/L)白藜芦醇苷的回收率分别为106.2%、97.8%和91.6%;检测血浆低、中、高3个浓度(1、20、100μg/L)白藜芦醇的回收率分别为113.2%、103.6%和93.4%。本方法具有灵敏、准确、快速的特点,可用于白藜芦醇苷的药代动力学研究。     

单泵柱切换离子色谱法分析复杂基体中痕量阴离子

本文通过离子色谱与柱切换技术联用实现了高浓度样品基体中的痕量阴离子检测.分别研究了不同类型基体的处理方法,使用商品化离子排斥柱和自制的聚合物色谱柱实现多种样品基体中痕量阴离子的检测.同时开发一种简化的单泵柱切换系统,利用抑制器将KOH淋洗液转化为水作为前处理柱的淋洗液,在同一个色谱系统中产生两种淋洗液,实现色谱分离与前...     

采用配备GPC纯化装置的GC/MS进行农产品中农药残留的快速分析

本文采用GPC-GC／MS在线连接系统和固相萃取的方法快速测定农产品中的农药残留。该方法首先用液-液分配法从均化的食物样品中提取农药,然后用PSA结合相进行固相萃取,最后进行GPC-GC／MS分析。GPC-GC／MS系统包括一套GPC净化装置,可以简化样品前处理步骤。把浓度为0．1 μg／g的97种农药添加到马铃薯、甘蓝和胡萝卜中,得到了比较好的回收率。整个分析过程大约需要50 min。     

On-line pretreatment using methylcellulose-immobilized cation-exchange restricted access media for direct liquid chromatography/mass spectrometric determination of basic drugs in plasma

A novel methylcellulose-immobilized restricted access media column with strong cation-exchange groups on an internal surface (MC-SCX) was evaluated for the direct injection analysis of basic polar drugs in plasma by column-switching liquid chromatography/mass spectrometry (LC/MS). Analytical conditions, including an automated pretreatment step and MS detection, were optimized for a series of basic drugs (doxepin, desipramine, imipramine, nortriptyline, amitriptyline, clomipramine). On-line pretreatment with the MC-SCX column followed by fast gradient analysis using a C18 column resulted in a total analysis cycle time of 7 min for each spiked plasma sample. More than 150 plasma samples spiked with target compounds were measured without compromising MS detection (relative standard deviations less than 11% for all compounds, and regression coefficients greater than 0.99).     

Development and application of a new on-line SPE system combined with LC-MS/MS detection for high throughput direct analysis of pharmaceutical compounds in plasma

A technique using a fully automated on-line solid phase extraction (SPE) system (Symbiosis, Spark Holland) combined with liquid chromatography (LC)-mass spectrometry (MS/MS) has been investigated for fast bioanalytical method development, method validation and sample analysis using both conventional C18 and monolithic columns. Online SPE LC-MS/MS methods were developed in the automated mode for the quantification of model compounds (propranolol and diclofenac) directly in rat plasma. Accuracy and precision using online SPE LC-MS/MS with conventional C18 and monolithic columns were in the range of 88-111% and 0.5-14%, respectively. Total analysis cycle time of 4 min per sample was demonstrated using the C18 column. Monolithic column allowed for 2 min total cycle time without compromising the quality and validation criteria of the method. Direct plasma sample injection without on-line SPE resulted in poor accuracy and precision in the range of 41-108% and 3-81%. Furthermore, the increase in back pressure resulted in column damage after the injection of only 60 samples.     

Ternary-column system for high-throughput direct-injection bioanalysis by liquid chromatography/tandem mass spectrometry

As a continuation of our efforts to improve our high-flow on-line bioanalytical approach for high-throughput quantitation of drugs and metabolites in biological matrices by high-performance liquid chromatography (LC) and tandem mass spectrometry (MS/MS), we have developed a ternary-column on-line LC/MS/MS system with dual extraction columns used in parallel for purification and an analytical column for analysis. The advantage of the dual extraction column system is that sample analysis can take place in one of the extraction columns while the other column is being equilibrated. Thus, the equilibration time does not add to the run time, hence shortening the injection cycle time and increasing the sample throughput. Moreover, the use of two extraction columns in parallel increases the number of samples that can be injected before the system fails due to an overused extraction column. Such a system has successfully been used to develop and validate a positive ion electrospray LC/MS/MS bioanalytical method for the quantitative determination of a guanidine-containing drug candidate in rat plasma. The system used for this work utilized two Oasis HLB extraction columns (1 x 50 mm, 30 microm), one C18 analytical column (3.9 x 50 mm, 5 microm), a ten-port switching value and a tandem mass spectrometer. The on-line analysis was accomplished by the direct injection of 10 microL of the sample, obtained by mixing a rat plasma sample 1:1 with an aqueous internal standard solution. Selected reaction monitoring (SRM) was utilized for the detection of the analyte and internal standard. The standard curve range was 1.00-200 ng/mL. The intra- and inter-day precision and accuracy were within 6.6%. The on-line purification step lasted for only 0.3 min and total run time was only 1.6 min.     

Simple and sensitive liquid chromatographic quantitative analysis of the novel marine anticancer drug Yondelis (ET-743, trabectedin) in human plasma using column switching and tandem mass spectrometric detection

The development of a simple and sensitive assay for the quantitative analysis of the marine anticancer agent Yondelis (ET-743, trabectedin) in human plasma using liquid chromatography (LC) with column switching and tandem mass spectrometric (MS/MS) detection is described. After protein precipitation with methanol, diluted extracts were injected on to a small LC column (10 x 3.0 mm i.d.) for on-line concentration and further clean-up of the sample. Next, the analyte and deuterated internal standard were back-flushed on to an analytical column for separation and subsequent detection in an API 2000 triple-quadrupole mass spectrometer. The lower limit of quantitation was 0.05 ng mL(-1) using 100 micro l of plasma with a linear dynamic range up to 2.5 ng ml(-1). Validation of the method was performed according to the most recent FDA guidelines for bioanalytical method validation. The time needed for off-line sample preparation has been reduced 10-fold compared with an existing LC/MS/MS method for ET-743 in human plasma, employing a labor-intensive solid-phase extraction procedure for sample pretreatment. The proposed column switching method was successfully applied in phase II clinical trials with Yondelis and pharmacokinetic monitoring.     

A highly automated 96-well solid phase extraction and liquid chromatography/tandem mass spectrometry method for the determination of fentanyl in human plasma

A high-throughput bioanalytical method based on automated sample transfer, automated solid phase extraction, and fast liquid chromatography/tandem mass spectrometry (LC/MS/MS) analysis, has been developed for the determination of the analgesic fentanyl in human plasma. Samples were transferred into 96-well plates using an automated sample handling system. Automated solid phase extraction (SPE) was carried out using a 96-channel programmable liquid-handling workstation using a mixed-mode sorbent. The extracted samples were then dried down, reconstituted and injected onto a silica column using an aqueous/organic mobile phase with tandem mass spectrometric detection. The method has been validated over the concentration range 0.05-100 ng/mL fentanyl in human plasma, based on a 0.25-mL sample size. The assay is sensitive, specific and robust. More than 2000 samples have been analyzed using this method. The automation of the sample preparation steps not only increased the analysis throughput, but also facilitated the transfer of the method between different bioanalytical laboratories of the same organization.     

Direct injection versus liquid-liquid extraction for plasma sample analysis by high performance liquid chromatography with tandem mass spectrometry.

Direct injection versus liquid-liquid extraction for post-dose human plasma sample analysis by high performance liquid chromatography with tandem mass spectrometry (LC/MS/MS) have been studied using a drug candidate compound. For the direct-injection method, an Oasis(R) HLB column (1 x 50 mm, 30 micrometer) was used as the on-line extraction column and a conventional Waters symmetry C18 column (3.9 x 50 mm, 5 micrometer) was used as the analytical column. Each plasma sample (100 microL) was mixed with 100 microL of a working solution of the internal standard in aqueous 0.05 M ammonium acetate (pH 6.9), and portions (10 microL) of these samples were then injected into the LC/MS/MS system. For the liquid-liquid extraction method, a YMC Basic C18 column (2.0 x 50 mm, 5 micrometer) was used as the analytical column. Each sample (0.5 mL) was extracted with methyl tert-butyl ether and the extract was reconstituted and injected into the LC/MS/MS system. The total analysis time for both methods was 2.0 min per sample. The accuracy, inter-day precision and intra-day precision obtained from the quality control samples were within 8% for both methods. The analysis results of post-dose human plasma samples showed that the deviations of 91% of the concentrations obtained using the direct-injection method were within +/-20% from the concentrations obtained using the liquid-liquid extraction method, and the overall average percentage deviation was -1.5%. The results showed that the two methods were equivalent in terms of total chromatographic run time, accuracy and precision. However, for a batch of 100 samples, the sample preparation time for the direct-injection method was only about 25% of the time required for liquid-liquid extraction. This decrease in sample preparation time resulted in the doubling of the overall sample analysis throughput.     

High-throughput biological sample analysis using on-line turbulent flow extraction combined with monolithic column liquid chromatography/tandem mass spectrometry

A high-throughput liquid chromatography/tandem mass spectrometry (LC/MS/MS) method, which combines on-line sample extraction through turbulent flow chromatography with a monolithic column separation, has been developed for direct injection analysis of drugs and metabolites in human plasma samples. By coupling a monolithic column into the system as the analytical column, the method enables running 'dual-column' extraction and chromatography at higher flow rates, thus significantly reducing the time required for the transfer and mixing of extracted fraction onto the separation column as well as the time for gradient separation. A strategy of assessing and reducing the matrix suppression effect on the on-line extraction LC/MS/MS has also been discussed. Experiments for evaluating the resolution, peak shape, sensitivity, speed, and matrix effect were conducted with dextromethorphan and its metabolite dextrorphan as model compounds in human plasma matrix. It was demonstrated that the total run time for this assay with a baseline separation of two analytes is less than 1.5 min.     

A novel on-line solid-phase extraction approach integrated with a monolithic column and tandem mass spectrometry for direct plasma analysis of multiple drugs and metabolites

An on-line solid-phase extraction liquid chromatography/tandem mass spectrometry (SPE LC/MS/MS) assay using a newly developed SPE column and a monolithic column was developed and validated for direct analysis of plasma samples containing multiple analytes. This assay was developed in an effort to increase bioanalysis throughput and reduce the complexity of on-line SPE LC/MS/MS systems. A simple column-switching configuration that requires only one six-port valve and one HPLC pumping system was employed for on-line plasma sample preparation and subsequent gradient chromatographic separation. The resulting analytical method couples the desired sensitivity with ease of use. The method was found to perform satisfactorily for direct plasma analysis with respect to assay linearity, specificity, sensitivity, precision, accuracy, carryover, and short-term stability of an eight-analyte mixture in plasma. A gradient LC condition was applied to separate the eight analytes that cannot be distinctly differentiated by MS/MS. With a run time for every injection of 2.8 min, a minimum of 300 direct plasma injections were made on one on-line SPE column without noticeable changes in system performance. Due to the ruggedness and simplicity of this system, generic methods can be easily developed and applied to analyze a wide variety of compounds in a high-throughput manner without laborious off-line sample preparation.     

The rapid identification of drug metabolites using capillary liquid chromatography coupled to an ion trap mass spectrometer

Capillary liquid chromatography (LC) using a 320 microns column and a flow rate of 10 microL/min has been coupled to an ion trap mass spectrometer using electrospray ionisation (ESI) to enable the rapid and effective identification of metabolites in urine, following oral administration of a novel human neutrophil elastase inhibitor, GW311616. Metabolites were identified from their mass (MS) spectra and tandem (MS/MS) mass spectra using minimal sample (1 microL of urine) and no sample pretreatment. Sensitivity assessment has shown that both molecular weight and structural information is obtainable on as little as 5 pg of compound, making the capillary LC/ion trap system as described an ideal analytical tool for the detection and characterisation of low level metabolites in biofluids (particularly when sample volume is limited). This level of detection was unattainable using a triple quadrupole mass spectrometer operating in full-scan mode, although 200 fg on column was detected using selected reaction monitoring target analysis.     

On-Line Sample Treatment LC System for MS Compatibility

In the present work, a new liquid chromatography–mass spectrometry (LC–MS) system with on-line pretreatment using column switching and a dilution function was developed. This system can be used under conventional high-performance liquid chromatography (LC) separation conditions, including mobile phases containing phosphate buffer. The built-in autodilution function greatly improves the trapping efficiency for target compounds, followed by desaltation that optimizes the ionization conditions for MS analysis. This fully automated two-dimensional LC system interfaced with mass spectrometry provided a powerful tool for the determination of impurity profiles in pharmaceutical research and the identification of traditional Chinese medicine in natural products.